AT56 是口服有活性的脂钙蛋白型前列腺素 D 合酶 (L-PGDS) 选择性抑制剂，其IC50=95 μM，Ki=75 μM。它能够特异性地抑制L-PGDS催化的 PGD2介导的嗜睡或疼痛反应。

AT56, a specific inhibitor of prostaglandin D2 synthase enzymatic activity, blunted adipogenic aldosterone effects.

162640-98-4

C25H27N5

397.526

DMSO:>10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years